Thursday, January 16, 2020

Tyra Biosciences Takes $50M For Oncology Drugs

Carlsbad-based Tyra Biosciences, a new startup developing therapies targeting acquires resistance in oncology, has raised $50M in its Series A funding, the company said last week. The round was o-led by Alta Partners, RA Capital Management, Boxer Capital of Tavistock Group, and Canaan. The company said it is aiming to develop very specific compounds targeting d

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.